Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also low ....see more
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
The global ultrasound probe disinfection market in terms of revenue was estimated to be worth $501 million in 2022 and is poised to reach $936 million by 2027, growing at a CAGR of 13.3% from 2022 to 2027. The updated version of the report covers the historical market for the ultrasound probe disinfection market for the years 2020 and 2021, the estimated market for 2022, and the forecast for 2027, along with the CAGR from 2022 to 2027. Market growth is largely driven by increasing awareness regarding high-level disinfection of semi-critical probes and growing demand for low-cost ultrasonography procedures. Infectious diseases acquired due to improper reprocessing of ultrasound probes demand high-level disinfection of endocavitary probes after use or during surgery.
The global orthopedic devices market in terms of revenue was estimated to be valued at $36.3 billion in 2022 and is poised to reach $48.1 billion by 2028, growing at a CAGR of 4.8% from 2022 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global acupuncture needles market in terms of revenue was estimated to be worth $240 million in 2022 and is poised to reach $308 million by 2027, growing at a CAGR of 5.1% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global dental digital x-ray market in terms of revenue was estimated to be worth $4.0 billion in 2022 and is poised to reach $7.0 billion by 2027, growing at a CAGR of 11.9% from 2022 to 2027. Key players in the market include Planmeca Oy (Finalnd), VATECH CO. Ltd (South Korea), DENTSPLY SIRONA Inc. (US), VAREX IMAGING CORPORATION (US), Envista Holdings Corporation (US), Acteon Group (France), Hefei Meyer Optometric Technology Inc. (China), Air Techniques, Inc. (US), and The Yoshida Dental Mfg. Co. (Japan).
The global patient handling equipment market in terms of revenue was estimated to be worth $10.4 billion in 2022 and is poised to reach $14.0 billion by 2027, growing at a CAGR of 6.2% from 2022 to 2027. The current edition of the report consists of an updated market overview along with updated market assessments across all segments from 2020 to 2027. Also, updated industry trends, technology analysis, pricing analysis, and patent analysis have been provided in the market overview chapter. The current edition of the report considers an ongoing economic recession and provides an impact of the same on market sizing. Detailed qualitative insights on the recession's impact by region have been provided across the regional analysis section.
The global antimicrobial susceptibility testing market in terms of revenue was estimated to be worth $3.6 billion in 2022 and is poised to reach $4.7 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027. As of 2022, prominent players of this market are bioMérieux SA (France), Becton, Dickinson, and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US) among others.
The global optical imaging market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 13.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global ultrasound probe covers market in terms of revenue was estimated to be worth $213 million in 2022 and is poised to reach $283 million in 2027, growing at a CAGR of 5.9% from 2022 to 2027. The incidence of hospital-acquired infections due to improper probe reprocessing has been drastically increasing in the recent past. This has led to an emerging awareness about infection control, especially with regards to ultrasound probes, which is one of the major drivers of the global market.
The global IVD quality control market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $1.6 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027. Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
The global ultrasound needle guides market in terms of revenue was estimated to be worth $274 million in 2022 and is poised to reach $369 million by 2027, growing at a CAGR of 6.1% from 2022 to 2027. The prominent players in the global market are Roper Technologies (CIVCO Medical Solutions) (US), Aspen Surgical (US), FUJIFILM Holdings Corporation (Japan), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), Argon Medical Devices (US), Hologic, Inc. (US), Remington Medical Inc. (US), Geotek Medical (Turkey), InnoFine (China), KOELIS (France), Rocket Medical (China), BIRR (Netherlands), IZI Medical (US), Sheathing Technologies, Inc. (US), weLLgo Medical Products GmbH (Germany), and Advance Medical Designs, Inc. (US).
The global lateral flow assays market in terms of revenue was estimated to be worth $20.5 billion in 2022 and is poised to reach $22.6 billion by 2027, growing at a CAGR of 2.0% from 2022 to 2027. The prominent players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), and Merck KGaA (Germany).
The global infection control market in terms of revenue was estimated to be worth $50.0 billion in 2022 and is poised to reach $58.3 billion by 2027, growing at a CAGR of 3.1% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global urinalysis market in terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.7 billion by 2027, growing at a CAGR of 8.1% from 2022 to 2027. Market growth is driven by the increased focus of government on disease screening, high prevalence of life style related diseases like diabetes and kidney disease and increasing initiatives to spread the awareness on diabetes and related diseases.
The global enteral feeding devices market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 6.9% from 2022 to 2027. The key players operating in the global market include Nestlé S.A. (Switzerland), Fresenius Kabi (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), B. Braun Melsungen AG (Germany), and Becton, Dickinson and Company (US).
The global therapeutic drug monitoring market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 9.6% from 2022 to 2027. The growth of this market is primarily driven by an amplifying focus on research experimentation associated with therapeutic drug monitoring and an increase in severe diseases. However, the requirement for massive capital investments and the hesitancy of compact hospitals to offer therapeutic drug monitoring services may restrain the growth of this market.
The global surgical robots market in terms of revenue was estimated to be worth $8.5 billion in 2022 and is poised to reach $18.4 billion by 2027, growing at a CAGR of 16.6% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global medical device contract manufacturing market in terms of revenue was estimated to be worth $71.2 billion in 2022 and is poised to reach $118.9 billion by 2027, growing at a CAGR of 10.8% from 2022 to 2027. Some of the key players in the global market include Plexus Corp. (US), TE Connectivity Ltd. (Switzerland), Flex Ltd. (Singapore), Integer Holdings Corporation (US), and Jabil Inc. (US).
The global patient positioning systems market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.7 billion by 2027, growing at a CAGR of 4.0% from 2022 to 2027. some prominent players in this market are Getinge AB (Sweden), Hill-Rom, Inc. (US), Stryker Corporation (US), Steris Plc. (US), Span-America Medical Systems, Inc. (US), Skytron, LLC. (US), Elekta AB (Sweden), C-RAD (Sweden), LEONI AG (Germany), and Mizuho OSI (US) among others.
The global advanced wound care market in terms of revenue was estimated to be worth $11.2 billion in 2022 and is poised to reach $17.7 billion by 2027, growing at a CAGR of 9.4% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global X-ray detectors market in terms of revenue was estimated to be worth $3.1 billion in 2022 and is poised to reach $4.0 billion by 2027, growing at a CAGR of 5.2% from 2022 to 2027. Prominent players in this market are Varex Imaging Corporation(US), Thales Group( France), Canon( Japan), Fujifilm Corporation (Japan), Agfa-Gevaert Group (Belgium) and Teledyne Technologies(US).
The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 7.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global compression therapy market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $4.9 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global Orthodontic Supplies Market boasts a total value of $6.9 billion in 2022 and is projected to register a growth rate of 7.9% to reach a value of $10.1 billion by 2027. Prominent players in this market are 3M (US), Envista Holdings Corporation (US), Dentsply Sirona (US), Align Technology (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), Dentaurum (Germany), TP Orthodontics (US), Great Lakes Dental Technologies (US), DB Orthodontics (UK), among others
The global endoscopic submucosal dissection market in terms of revenue was estimated to be worth $347 million in 2022 and is poised to reach $483 million by 2027, growing at a CAGR of 6.9% from 2022 to 2027. The rising incidence of target diseases such as cancer is expected to accelerate the need for endoscopic procedures, which, in turn, will propel the growth of this market in the coming years.
The global in vitro diagnostics market in terms of revenue was estimated to be worth $115.8 billion in 2022 and is poised to reach $144.7 billion by 2027, growing at a CAGR of 4.6% from 2022 to 2027. Prominent players in the in vitro diagnostics market include Roche Diagnostics (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Siemens Healthineers AG (Germany), and Thermo Fisher Scientific, Inc (US). Other players in this market include, Sysmex Corporation (Japan), Becton, Dickinson and Company (BD, US), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), bioMérieux SA (France), Agilent Technologies, Inc. (US), DiaSorin S.p.A (Italy), Illumina, Inc. (US), Hologic, Inc. (US), Devyser (Sweden), PerkinElmer Inc. (US), Chembio Diagnostics, Inc. (US), SurModics, Inc. (US), Accelerate Diagnostics, Inc. (US), and Merck KGaA (Germany).
The sterilization services market is projected to reach USD 5.9 billion by 2027, at a CAGR of 5.5% during the forecast period. The global key players operating in this market are STERIS plc (US), Sotera Health Company (US), Stryker Corporation (US), Advanced Sterilization Products (ASP, US), E-BEAM Services, Inc. (US), MMM Group (Germany), Belimed AG (Switzerland), BGS Beta-Gamma-Service GmbH & Co. KG (Germany), Medistri SA (Switzerland), and Noxilizer, Inc. (US) are key players in the sterilization services market.
The endoscopy equipment market is projected to grow from USD 28.9 billion in 2022 to USD 40.6 billion by 2027, growing at a CAGR of 7.0% during the forecast period. Prominent players in the endoscopy equipment market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker Corporation (US), Boston Scientific Corporation (US), JOHNSON & JOHNSON (US), Fujifilm Holdings Corporation (Japan), Medtronic, Inc. (Ireland), HOYA Corporation (Japan), Nipro Corporation (Japan), Intuitive Surgical, Inc. (US) and Smith & Nephew plc (UK).
The veterinary reference laboratory market is expected to grow from USD 4.1 billion in 2022 to USD 6.4 billion by 2027, at a CAGR of 9.3% during the forecast period. Prominent players in the Veterinary Reference Laboratory Market are IDEXX Laboratories, Inc. (US), VCA, Inc. (US), GD Animal Health (Netherlands), Zoetis Inc. (US), NEOGEN Corporation (US), LABOKLIN GmbH (Germany), SYNLAB International GmbH (Germany), Heska Corporation (US), Virbac (US) and Thermo Fisher Scientific, Inc. (US).
The global point of care diagnostics market in terms of revenue was estimated to be worth $45.4 billion in 2022 and is poised to reach $75.5 billion by 2027, growing at a CAGR of 10.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global minimal residual disease testing market boasts a total value of $1.2 Billion in 2022 and is projected to register a growth rate of 14.0% to reach a value of $2.3 billion by 2027. The major players operating in this market are Labcorp Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Guardant Health (US), Sysmex Corporation (Japan), NeoGenomics Laboratories, Inc. (US), Adaptive Biotechnologies Corporation (US), ArcherDX, Inc. (US), Asuragen Inc. (US), Arup Laboratories Inc. (US), Bio-Rad Laboratories, Inc. (US), Cergentis B.V. (Netherlands), Molecular MD (ICON plc) (Ireland), Invivoscribe, Inc. (US), Mission Bio, Inc. (US), Natera, Inc. (US), Opko Health, Inc. (US), Quest Diagnostics (US), and Genetron Health (China), among others.
The global HPV testing and Pap test market in terms of revenue was estimated to be worth $4.9 billion in 2022 and is poised to reach $9.2 billion by 2027, growing at a CAGR of 13.2% from 2022 to 2027. The major players operating in this market are Abbott Laboratories (US), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US), Hologic, Inc. (US), Quest Diagnostics (US), Qiagen N.V. (Netherland), Seegene, Inc. (US), Femasys, Inc. (US), Arbor Vita Corporation (US) and Mylab Discovery Solutions Pvt. Ltd. (India).
The global home healthcare market in terms of revenue was estimated to be worth $226 billion in 2022 and is poised to reach $340.2 billion by 2027, growing at a CAGR of 8.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global Hemato Oncology Testing Market boasts a total value of $2.9 billion in 2022 and is projected to register a growth rate of 14.2% to reach a value of $5.6 billion by 2027. Prominent players in this market are Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US), and Illumina (US).
The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. The vascular patches market is dominated by players such as Baxter International, Inc. (US), LeMaitre Vascular, Inc. (US), and W. L. Gore & Associates, Inc. (US).
The microcatheter market is expected to grow from USD 828 million in 2022 to USD 1,082 million by 2027, at a CAGR of 5.5% during the forecast period. As of 2022, prominent players in the microcatheter market are Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan).
The sternal closure systems market size is projected to reach USD 2.9 billion by 2027, at a CAGR of 5.1%. The major players operating in this market are DePuy Synthes (US), Zimmer Biomet Holdings, Inc. (US), KLS Martin Group (US), B. Braun SE (Germany), and Stryker (US).
The global ventilator market in terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.4 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. The prominent players in the ventilators market are Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Vyaire Medical, Inc. (US), Getinge AB (Sweden), Drägerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Hamilton Medical (Switzerland), GE Healthcare (US), Air Liquide (France), Asahi Kasei Corporation (Japan), Allied Healthcare Products, Inc. (US), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), Skanray Technologies (India), Baxter International Inc, (US), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Leistung Ingeniería SRL (Argentina), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), and HEYER Medical AG (Germany).
The global Liquid Biopsy Market boasts a total value of $4.3 billion in 2022 and is projected to register a growth rate of 18.3% to reach a value of $10.0 billion by 2027. The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Bio-Rad Laboratories, Inc. (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences, Inc. (US), Exosome Diagnostics, Inc. (US), Agena Bioscience, Inc. (US), MedGenome Inc. (US), Epigenomics AG (Germany), and Personal Genome Diagnostics, Inc. (US).
The needles market is projected to reach USD 10.6 billion by 2027, at a CAGR of 6.7% during the forecast period. The major players in the Needles Market are Becton, Dickinson, and Company (US), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), and Stryker Corporation (US).
The global cancer profiling market in terms of revenue was estimated to be worth $9.7 billion in 2022 and is poised to reach $16.0 million by 2027, growing at a CAGR of 10.6% from 2022 to 2027. The growth in this market is driven by rising funding investments in cancer research and technological advancements in profiling technologies. In addition, the growing need for point-of-care diagnostics is expected to offer significant growth opportunities for market players. On the other hand, a low biomarker discovery-to-approval ratio and a poor regulatory and reimbursement scenario challenge the growth of the cancer profiling market.
The global infusion pumps market in terms of revenue was estimated to be worth $14.7 billion in 2022 and is poised to reach $20.5 billion by 2027, growing at a CAGR of 7.0% from 2022 to 2027. Prominent players in the infusion pump market include Becton, Dickinson and Company (US), Baxter International Inc. (US), B. Braun Melsungen AG (Germany), Smiths Medical (US), Fresenius Kabi (Germany), and ICU Medical, Inc. (US). These players adopted major growth strategies such as product launches & approvals, collaborations, and expansions. Other prominent players in the market include Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), Tandem Diabetes Care, Inc. (US), JMS Co., Ltd. (Japan), Insulet Corporation (US), Roche Diagnostics (Switzerland), Zyno Medical (US), Teleflex, Inc. (US), Shenzhen Mindray Bio-Medical Electronics co., ltd. (China), Micrel Medical Devices SA (Greece), Ypsomed Holding AG (Switzerland), InfuTronix Solutions LLC (US), SOOIL Development Co., Ltd (South Korea), Shenzhen MedRena Biotech Co., Ltd. (China), Eitan Medical (Israel) and CODAN Medizinische Geräte GmbH & Co KG (Germany).
The global ELISpot and FluoroSpot Assays Market boasts a total value of $274 million in 2022 and is projected to register a growth rate of 7.3% to reach a value of $390 million by 2027. The major players in the ELISpot and FluoroSpot Assays Market are Oxford Immunotec (UK), Cellular Technology Limited (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam plc. (UK), Bio-Techne.(US), Mikrogen Diagnostik (Germany), Autoimmun Diagnostika GmbH (Germany), U-CyTech (Netherland), and Medix Biochemica (Finland)
The global sterilization equipment market in terms of revenue was estimated to be worth $13.7 billion in 2022 and is poised to reach $20.0 billion by 2027, growing at a CAGR of 7.9% from 2022 to 2027. The major players operating in this market are STERIS Corporation (US), Getinge AB (Sweden), and Sotera Health (US).
The global dental implants and prosthetics market in terms of revenue was estimated to be worth $9.9 billion in 2022 and is poised to reach $14.1 billion by 2027, growing at a CAGR of 7.2% from 2022 to 2027. The current edition of the report consists of an updated market overview, which includes information on the key conferences and events during 2022–2023, regulatory bodies, government agencies, and other organizations, as well as the key stakeholders and their buying criteria.
The global biological safety cabinet market in terms of revenue was estimated to be worth $0.2 billion in 2022 and is poised to reach $0.4 billion by 2027, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by increased research in the pharmaceutical industry and the rapid growth in vaccine development for communicable diseases.
The cardiac marker testing Market is expected to grow from USD 5.0 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 8.7% during the forecast period. Prominent players in the cardiac marker testing market include F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Siemens Healthineers AG (Germany), PerkinElmer, Inc. (US), bioMérieux SA (France), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), DiaSorin (Italy), and Tosoh Corporation (Japan), LSI Medience Corporation (Japan), Quidel Corporation (US), Randox Laboratories (UK), Guangzhou Wondfo Biotech Co., Ltd. (China), Boditech Med Inc. (South Korea), Tulip Diagnostics (P) Ltd (India), BTNX Inc. (Canada), Response Biomedical (Canada), Alfa Scientific Designs, Inc. (US), CTK Biotech, Inc. (US), Creative Diagnostics (US), LifeSign LLC. (US), CardioGenics Holdings Inc (Canada), and Atlas Medical GmbH (Germany).
The global bone growth stimulator market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The growing demand for bone growth stimulators in spinal fusion surgeries, delayed union and nonunion bone fracture applications, and the increasing demand for bone growth stimulator devices are the major driving factors of this market.
The OTC braces & supports market is expected to grow from USD 942 million in 2022 to USD 1,286 million by 2027, at a CAGR of 6.4% during the forecast period. The major players operating in this market are 3M (US), DJO Global (US), Essity (Sweden), Zimmer Biomet Holdings, Inc (US), Ottobock Healthcare (Germany), Össur HF (Iceland), medi GmbH (Germany), DeRoyal Industries Inc (US), Bauerfeind AG (Germany), Bird & Cronin (US), Breg Inc. (US), Thuasne (France), TruLife Group (Ireland), Alcare (Japan), Prim SA (Spain), and Foundation Wellness (US).
The leukapheresis market is expected to grow from USD 65 million in 2022 to USD 98 million by 2027, at a CAGR of 8.5% during the forecast period. Key players in the leukapheresis products market include Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany).